These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6473997)

  • 1. [Endocrine consequences of beta thalassemia major].
    Houyoux C; Bourguignon JP; Chantraine JM; Reginster-Bous M; Lambotte C
    Schweiz Rundsch Med Prax; 1984 Jul; 73(29):906-13. PubMed ID: 6473997
    [No Abstract]   [Full Text] [Related]  

  • 2. [The endocrine complications in thalassemia major].
    Anastasi S; Caruso V; Magnano C; Leocata A
    Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical management of homozygous beta-thalassemia.
    Cividalli G
    Haematologica; 1979 Feb; 64(1):1-12. PubMed ID: 109360
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.
    Letsky EA
    Birth Defects Orig Artic Ser; 1976; 12(8):31-41. PubMed ID: 1009233
    [No Abstract]   [Full Text] [Related]  

  • 5. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine changes in thalassemia major].
    Sinisi AA; Criscuolo T; Bellastella A; Perrone L; Barone M; Castaldo G; Faggiano M
    Minerva Pediatr; 1986 May; 38(10):375-83. PubMed ID: 3736515
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of thalassemia in Los Angeles.
    Hyman CB; Ortega JA; Costin G; Landing B; Lazerson J; Leimbrock S; Lurie P
    Birth Defects Orig Artic Ser; 1976; 12(8):43-52. PubMed ID: 1009234
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
    Kattamis CA; Kattamis AC
    Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
    [No Abstract]   [Full Text] [Related]  

  • 10. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008).
    Canatan D
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):24-7. PubMed ID: 23128337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future perspectives in the treatment of thalassemia major].
    Girot R
    Ann Pediatr (Paris); 1985 Nov; 32(9):801-7. PubMed ID: 3911858
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical appraisal of growth retardation and pubertal disturbances in thalassemia.
    Chatterjee R; Bajoria R
    Ann N Y Acad Sci; 2010 Aug; 1202():100-14. PubMed ID: 20712780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in the overall management of thalassemia.
    Propper RD
    Ann N Y Acad Sci; 1980; 344():375-83. PubMed ID: 6930877
    [No Abstract]   [Full Text] [Related]  

  • 14. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalassemia.
    Brown EB
    Prog Clin Biol Res; 1983; 127():33-42. PubMed ID: 6889403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertransfusion, chelating and immunocorrective therapy in beta-thalassemia major].
    Zeĭnalova AA; Ragimov AA; Dashkova NG; Mamedova FR; Kurbanova SA
    Pediatriia; 1987; (2):55-60. PubMed ID: 3575062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-thalassemia: molecular bases, physiopathology, prevention and treatment].
    Cao A
    Minerva Pediatr; 1991 Dec; 43(12):745-51. PubMed ID: 1798400
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation.
    See WQ; Tung JY; Cheuk DK; Hwang YY; Ip JK; Cheung PT; Chan GC; Ha SY
    Bone Marrow Transplant; 2018 Mar; 53(3):356-360. PubMed ID: 29269804
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern management of thalassemia.
    Festa RS
    Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolytic anemia: thalassemia syndromes.
    Propper RD
    Pediatr Ann; 1980 Aug; 9(8):300-7. PubMed ID: 7413285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.